PRMT2 and ulcerative colitis: Higher PRMT2 expression is observed in intestinal specimens from patients with Crohn’s disease and ulcerative colitis, additionally, PRMT2 represses the SOCS3 promoter via histone H3R8 asymmetric dimethylation, thereby promoting the development of DSS-induced colitis [18].